Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Central Nervous System Tumor, Pediatric: early-phase trial registry
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Central Nervous System Tumor, Pediatric: 2 US clinical trials tracked, none currently recruiting.
Central Nervous System Tumor, Pediatric is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of South Florida, running 1 of these trials.
Enrollment posture brief
Registry condition central-nervous-system-tumor-pediatric
OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Central Nervous System Tumor, Pediatric has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Central Nervous System Tumor, Pediatric on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Central Nervous System Tumor, Pediatric is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Seattle Children's Hospital
NCT03500991
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy
University of South Florida
NCT01346267
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Central Nervous System Tumor, Pediatric records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Central Nervous System Tumor, Pediatric trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Central Nervous System Tumor, Pediatric page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Central Nervous System Tumor, Pediatric trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- University of South Florida sponsors the most Central Nervous System Tumor, Pediatric trials on record, review their full trial history before evaluating a specific study. See University of South Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Central Nervous System Tumor, Pediatric condition card totals 2 registered trials; most-linked intervention Placebo Acupressure Band; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.